Skip to content

The Efficacy and Safety of Leard- Ngam Remedy Powder versus Mefenamic Acid on Relieving Primary Dysmenorrhea

The Efficacy and Safety of Leard- Ngam Remedy Powder versus Mefenamic Acid on Relieving Primary Dysmenorrhea

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190114002
Enrollment
Unknown
Registered
2019-01-14
Start date
2017-12-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea Leard&#45

Interventions

Orally three times a day before meals for three days starting from the first day of menstruation (3 months)
Experimental Drug
Leard&#45
Ngam remedy

Sponsors

Center of Excellence in Applied Thai Traditional Medicine
Lead Sponsor
Faculty of Thammasat University
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. suffer from primary dysmenorrhea diagnosed by a gynecologist 2. have a regular menstrual cycle 3. require analgesic drug for relieving pain. 4. Volunteers must pass the screening criteria based on the questionnaire and have pain score not less than 3

Exclusion criteria

Exclusion criteria: 1. pregnant or breast feeding 2. taking oral contraceptive medicine or contraceptive injections for 6 months prior to enrollment. 3. having severe gastrointestinal, gynaecological, or autoimmune diseases 4. have parturition, pregnant or abortion 5. receive gynaecological surgery within 1 year prior to the trial 6. have medicinal and herbal sensitivities

Design outcomes

Primary

MeasureTime frame
Pain Assessment Change form baseline at 7 months. every month (7 months) using NRS for evaluate patient’s menstrual pain.

Secondary

MeasureTime frame
symptoms of menstruation every month (7 months) Using the menstrual symptom Questionnaire.

Countries

Thailand

Contacts

Public ContactNuanjan Jaiarree

Faculty of medicine

nuanjan_j@yahoo.com+6695519395

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026